During the past several decades, survivors, healthcare professionals, researchers, and supporters have brought their voices together to drown out the silence that once surrounded breast cancer. In 1985, the American Cancer Society and the pharmaceutical division of Imperial Chemical Industries (now part of AstraZeneca, an oncology drug manufacturing company) joined forces in establishing October as
